- Connected Health Research - Connected Health Research Frost & Sullivan Integrated Practice Management Software (IPMS) Market Primary Care IT 2.0 in Europe, Forecast to 2022 There is a high demand for more efficiency of time and resources in General Physician (GP) practices that are extremely strained under the increasing chronic disease burden and decreasing staff numbers. There is also increasing reliance on healthcare information technology, driven by a supportive regulatory environment, and it is contributing to a need to upgrade systems across primary healthcare for efficient functioning which is augmenting market growth. Across Europe, basic primary care IT is well established, but is limited to patient administration and healthcare information management at a practice level. With the rise of integrated care models, the role of primary care in the healthcare ecosystem is much more than that of a gatekeeper and to meet the demand, practices will have to look at solutions that can manage and share information within and outside the network; thereby, requiring integrated practice management software.--BEGIN PROMO--

Research Highlights

The study identifies opportunities by country and for all the different ecosystem components, especially for:

  • Value-based Care: improving performance assessment tools in primary care
  • Social Prescribing: Increasing role of GP practices in integrated and community care
  • Relationship Continuity: GPs to play an increasingly important part in patient-centric care
  • Retail Health: rise of walk-in clinics and community pharmacies as a part of primary care

Key Features

The objective of this research study is understanding the emerging concept of integrated practice management software and its adoption in primary care centers in Europe. Integrated practice management software is an end-to-end solution that offers clinical, administrative, and billing functions. With integrated EHR capabilities, these solutions offer functionalities, including ePrescription, scheduling, appointment systems, and portals for messaging as well as billing. Such solutions are an advancement over practice management systems that were primarily focusing on the billing & administrative function (particularly patient scheduling). The addressable market includes primary care centers operated by solo or group GP practices. This research study does not cover outpatients centers and ambulatory care units that are affiliated to hospitals. Countries covered for market forecast are the UK, France, Germany, Spain, Italy, Scandinavia, and Benelux. The study also discusses the emerging market in Estonia, Poland, and Austria qualitatively.

Key Issues Addressed

  • What is integrated practice management software? What has driven the development of these IT solutions?
  • How is the adoption of IT in primary care evolving? What is the impact and adoption of new technologies?
  • How are the initiatives at the national and regional level for driving adoption of integrated practice management software?
  • What is the current vendor landscape for integrated practice management software in Europe and how is it expected to evolve over the next five years?
  • What are the most promising growth opportunities and key investment areas over the next 5 years?

Author: Chandni Mathur


Fri, 11 Jan 2019 00:00:00 +0000
Digital Pathology: Roadmap to the Future of Medical Diagnosis Digital Pathology encompasses the use of optmized pathology workstations, whole slide imaging, image analysis, image management, laboratory information management system, use of machine learning, data handling and storage. Pathology is one of the most important fields in medicine, as the service provides investigation and validation platform in lieu of a medical condition of a patient. Traditional methods of pathology involves slide preparation, traditional microscopy, result interpretation from microscopy by pathologist onto an information management system followed by physical storage of slides for a prescribed timeline. According to numerous research and surveys conducted across the world, the request for pathology services are increasing by a healthy percentage year-on-year which can be attributed to the increase in cancer prevalence across the globe, ageing population amongst a number of other factors. Factoring in to the above the number of experienced pathologists available at the moment and ones about to retire, the scenario for pathology services may start to look grim. Therefore, an urgent solution is needed to tackle the challenges pertaining increase in diagnosis of patients and unreasonable timelines that pathologists are facing currently with the traditional pathology methods. Proper deployment of Digital Pathology solutions have the demonstrated ability to streamline the workflow of pathology services, and can potentially increase the efficiency of the workflow and decrease the time for diagnosis. Artificial Intelligence (AI), Machine learning and deep learning are terms that refer to the technology that possesses the ability to recognize patterns from the database that it is initially provided with and matching to it to similar data set thus mapping the results based on past occurrences. The use of AI in digital pathology has gained momentum over the last few years. Notably, the FDA approved an AI-tool as a primary diagnosis tool as recently as in 2017 for wrist fractures. The application of AI for pathology services are innumerable considering the fact the pathological services give rise to a lot of information. Information or data sets that can serve as the basis of creating deep learning digital pathology tools that can act as a diagnosis supplement tool for pathologists, thus increasing the speed of diagnosis, maybe accuracy and certainly providing the potential to prioritize diagnosis cases based on severity for the pathologists to review. The next decade of the medical field is set to witness the transformation of digital pathology services by AI tools. Sat, 29 Dec 2018 00:00:00 +0000 Incisionless Surgeries: Envisioning The Future of Surgical Technology The shift towards value-based care have forced hospitals to adopt minimally invasive surgical procedures, which offers better clinical outcomes in the form of lesser operating time, reduced post-surgical complications, faster recovery speeds, low bleeding rates during performance of the procedure, and reduction in the overall costs of such procedures. Incisionless surgeries are proving to the gold standard for accomplishing a range of diagnostic and therapeutic procedures for managing chronic and severe conditions not limited to cancer. Increasing emphasis on value-based care has imposed pressure on hospitals to source technologies that can help retain existing procedural volumes while maximizing the clinical outcomes and costs associated with such incisionless procedures. This research service focuses on various technologies that enable hospitals to maximize the value of incisionless surgeries prescribed to patients (especially old age and critical cases), while achieving an optimal balance on the volume of procedures performed within the same premises. The first section focuses on the current industry snapshot and segmentation of the global incisionless surgeries market. The section outlines the supplier landscape, major end-user segments and products that cater to various clinical applications. The section also brings out the critical growth factors that differentiate competitive performance and outlines the key R&PD initiatives that are necessary to achieve optimal balance between procedural volumes and value. The second section focuses on the critical technology success factors that are necessary for hospitals to improve the value of incisionless surgeries, while optimizing their procedural volumes critical to meet revenue and business performance. The section also uncovers technology factors that are critical to retaining or enhancing procedural volumes, focusing on improved turnaround time, efficient OR use and reduced costs of laparopscopic procedures such as use of handheld microsurgical instruments. The third section focuses on the prioritization of technology factors that contribute to procedural volumes and value, which demonstrate an optimal balance between supply of such technologies to meet the existing demand. The section also uncovers the critical business models that enable hospitals achieve their targets fixed for procedural value and volumes for various customer segments and regions. Fri, 28 Dec 2018 00:00:00 +0000 Global Healthcare Market Outlook, 2019 Globally, 2019 will be a year of value-based care, as outcome-based care focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 elections in emerging markets such as Asia, Africa, and Central and Eastern European countries. Future drugs and devices R&D investments will be more targeted to meet the unique needs of emerging markets. As the lines between retail, IT, and healthcare markets continue to blur, digital marketplace providers such as Amazon will dominate the home health space, but will find it difficult to compete in the traditional B2B hospital/providers space dominated by established participants. Non-traditional participants such as Amazon, Ali Health, Microsoft, and IBM with digital technologies will provide the required impetus to public health systems to ensure accessibility and affordability of care. During 2019, digital health will start to come of age favorable reimbursement policies toward clinically relevant digital health applications will expand care delivery models beyond physical medicine to include behavioral health, digital wellness therapies, dentistry, nutrition, and prescription management.--BEGIN PROMO--

Research Scope

In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare market in 2019. The sectors covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for the upcoming year. The study provides guidance on where to find the greatest opportunities for expansion.

Key Features

Predictions for the global healthcare market in 2019 include:

  • Value-based care progressing globally
  • Artificial Intelligence (AI) exploding across the healthcare and life sciences ecosystem post flagship level use cases yielding positive results
  • Digital health coming of age with increased focus on individual care
  • Asia becoming the new local innovation hub for global drug and device OEMs
  • Healthcare data analytics focus shifting from Big Data to meaningful small data by hospital specialty
  • Healthcare to be a dominant vertical in voice applications as HIPAA-compliant voice and chatbot applications for healthcare gain prominence
  • Blockchain move from hype to reality with initial commercial implementations across focused B2B enterprise blockchain applications
  • Innovative private insurance models shaking up the healthcare payer market

Key Issues Addressed

  • What are the top predictions for healthcare markets in 2018?
  • What are the market revenues and growth rates expected for the global healthcare market?
  • What are the key projections and growth opportunities for major healthcare market segments?
  • What are the major macro and micro-regional/country-level trends specific to the healthcare market?
  • What are the key technologies and growth opportunities to watch out for during 2018?

Author: Kamaljit Behara

Wed, 26 Dec 2018 00:00:00 +0000
The Future of Patient Engagement 2.0 in Europe, 2018 Healthcare today is not about just going to the doctor at the time of illness or on regular appointments to check the overall disease progression. It is shifting to a more proactive rather than reactive approach with patients being more aware and willing to be involved in their own health. The traditional culture of healthcare and how people engage in healthcare is being dramatically reshaped by new cultural attitudes and the pervasive adoption of mobile phones/smartphones/social media by the general population as well as digital health tools increasingly used by healthcare providers. This opens up new possibilities for reshaping behaviors, especially for younger demographics. Further, health systems around the world are reeling under the pressure of rising costs, shortage of personnel, and the ever-increasing burden of chronic ailments. Digital health solutions are the saviors in such a landscape driving Patient Engagement 2.0. Not only do the IT solutions empower the patients, they also provide a cost-effective alternate channel for managing chronic patients. Broadly, digital health solutions cater to patient touch points across the care continuum and target clinical (remote monitoring, telehealth etc.), administrative (appointment scheduling, reminders etc.), and financial (billing, payer communications etc.) functions. A plethora of pure-play patient engagement companies are offering innovative solutions. EHR providers and medical device companies are not far behind. Different vendor types are targeting different gaps in the care journey. Innovations and start-up activity is abundant in this area with trends such as healthcare consumerization shaping up. Increasingly, there is a demand for clinical-grade digital solutions which offer the ease of use of consumer-grade devices and the accuracy and efficacy of medical-grade ones. Europe is emerging as a strong market with some countries becoming more attractive for such solutions. The regulatory framework of countries, IT infrastructure, and sociocultural factors have a major impact on the uptake of patient engagement solutions. The value of engaging patients digitally is not just being seen among the healthcare providers, but also with medical diagnostics, devices, pharmaceuticals, and insurance providers. As the report title reads, There is something for everyone . The stakeholders of the healthcare ecosystem should not look at patient engagement as a one-time activity, but as a cultural shift in the change of mind set and way of life. This report covers the current scenario for patient engagement in Europe and among stakeholders and also delves into growth opportunity areas for vendors to exploit in the next five years. Author: Chandni Mathur Fri, 30 Nov 2018 00:00:00 +0000